These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 1476539

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Buspirone augmentation of fluoxetine in obsessive-compulsive disorder.
    Markovitz PJ, Stagno SJ, Calabrese JR.
    Am J Psychiatry; 1990 Jun; 147(6):798-800. PubMed ID: 2188516
    [Abstract] [Full Text] [Related]

  • 3. Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder.
    Grady TA, Pigott TA, L'Heureux F, Hill JL, Bernstein SE, Murphy DL.
    Am J Psychiatry; 1993 May; 150(5):819-21. PubMed ID: 8480832
    [Abstract] [Full Text] [Related]

  • 4. Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder.
    Jenike MA, Baer L, Buttolph L.
    J Clin Psychiatry; 1991 Jan; 52(1):13-4. PubMed ID: 1988411
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The addition of buspirone to SSRI in the treatment of adolescent obsessive-compulsive disorder. A study of six cases.
    Thomsen PH, Mikkelsen HU.
    Eur Child Adolesc Psychiatry; 1999 Jun; 8(2):143-8. PubMed ID: 10435463
    [No Abstract] [Full Text] [Related]

  • 10. A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.
    Pigott TA, L'Heureux F, Hill JL, Bihari K, Bernstein SE, Murphy DL.
    J Clin Psychopharmacol; 1992 Feb; 12(1):11-8. PubMed ID: 1552034
    [Abstract] [Full Text] [Related]

  • 11. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.
    McDougle CJ, Goodman WK, Leckman JF, Holzer JC, Barr LC, McCance-Katz E, Heninger GR, Price LH.
    Am J Psychiatry; 1993 Apr; 150(4):647-9. PubMed ID: 8465885
    [Abstract] [Full Text] [Related]

  • 12. Ritanserin as adjunct to fluoxetine treatment of OCD patients with psychotic features.
    Bach M, Aigner M, Lenz G.
    Pharmacopsychiatry; 1997 Jan; 30(1):28-9. PubMed ID: 9065968
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treatment of adolescent obsessive-compulsive disorder with a clomipramine-fluoxetine combination.
    Simeon JG, Thatte S, Wiggins D.
    Psychopharmacol Bull; 1990 Jan; 26(3):285-90. PubMed ID: 2274627
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Buspirone in obsessive-compulsive disorder.
    Watts VS, Neill JR.
    Am J Psychiatry; 1988 Dec; 145(12):1606. PubMed ID: 3195684
    [No Abstract] [Full Text] [Related]

  • 19. Trazodone-fluoxetine combination for treatment of obsessive-compulsive disorder.
    Swerdlow NR, Andia AM.
    Am J Psychiatry; 1989 Dec; 146(12):1637. PubMed ID: 2589561
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.